MedTrace Logo

Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section

NCT03318536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2018-05-16

No results posted yet for this study

Summary

The aim of the present study is to quantify the dose and usage of sympathomimetics used in caesarean section.

Conditions

Interventions

DRUG

Granisetron Hydrochloride

Patients received Granisetron.

DRUG

No Granisetron

Patients who did not receive Granisetron.

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Kai Zacharowski, Prof. Dr. med. · Department of Anesthesia, Intensive Care Medicine and Pain Therapy

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-05
Primary Completion
2017-11-01
Completion
2018-02-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03318536 on ClinicalTrials.gov